Suppr超能文献

相似文献

4
Reduced Clot Stability by Thromboelastography as a Potential Indicator of Procedure-Related Bleeding in Decompensated Cirrhosis.
Hepatol Commun. 2020 Dec 12;5(2):272-282. doi: 10.1002/hep4.1641. eCollection 2021 Feb.
5
TEG-based transfusion protocol is associated with decreased blood product use without increased risk of hemoperitoneum.
Hepatol Commun. 2023 Oct 27;7(11). doi: 10.1097/HC9.0000000000000292. eCollection 2023 Nov 1.
7
Siglec-7 as a Novel Biomarker to Predict Mortality in Decompensated Cirrhosis and Acute Kidney Injury.
Dig Dis Sci. 2016 Dec;61(12):3609-3620. doi: 10.1007/s10620-016-4316-x. Epub 2016 Sep 21.
9
Hemoperitoneum in cirrhotic patients without abdominal trauma or tumor.
Hepatobiliary Pancreat Dis Int. 2011 Dec;10(6):644-8. doi: 10.1016/s1499-3872(11)60109-4.
10
[Analysis of risk factors for acute kidney injury in patients with decompensated cirrhosis].
Zhonghua Gan Zang Bing Za Zhi. 2014 Jun;22(6):420-4. doi: 10.3760/cma.j.issn.1007-3418.2014.06.005.

引用本文的文献

3
Paracentesis outcomes from a medicine procedure service at a tertiary care transplant center.
J Hosp Med. 2025 Sep;20(9):943-952. doi: 10.1002/jhm.70037. Epub 2025 Mar 27.
4
Prediction and prevention of post-procedural bleedings in patients with cirrhosis.
Clin Mol Hepatol. 2025 Feb;31(Suppl):S205-S227. doi: 10.3350/cmh.2024.0928. Epub 2025 Feb 18.
5
Hematological abnormalities in liver cirrhosis.
World J Hepatol. 2024 Sep 27;16(9):1229-1244. doi: 10.4254/wjh.v16.i9.1229.
6
Does the Use of Viscoelastic Hemostatic Assays for Periprocedural Hemostasis Management in Liver Disease Improve Clinical Outcomes?
Transfus Med Rev. 2024 Jul;38(3):150823. doi: 10.1016/j.tmrv.2024.150823. Epub 2024 Mar 19.
8
How to assess hemostasis in patients with severe liver disease.
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):267-273. doi: 10.1182/hematology.2023000479.
9
How to manage hemostasis in patients with liver disease during interventions.
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):274-280. doi: 10.1182/hematology.2023000480.

本文引用的文献

1
Changing Concepts of Cirrhotic Coagulopathy.
Am J Gastroenterol. 2017 Feb;112(2):274-281. doi: 10.1038/ajg.2016.498. Epub 2016 Nov 1.
2
Acute Kidney Injury in Patients with Cirrhosis.
J Clin Transl Hepatol. 2015 Sep 28;3(3):195-204. doi: 10.14218/JCTH.2015.00015. Epub 2015 Sep 15.
5
Coagulation in liver disease: a guide for the clinician.
Clin Gastroenterol Hepatol. 2013 Sep;11(9):1064-74. doi: 10.1016/j.cgh.2013.02.026. Epub 2013 Mar 16.
6
Hemostatic defects in liver and renal dysfunction.
Hematology Am Soc Hematol Educ Program. 2012;2012:168-73. doi: 10.1182/asheducation-2012.1.168.
7
Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions.
J Vasc Interv Radiol. 2012 Jun;23(6):727-36. doi: 10.1016/j.jvir.2012.02.012. Epub 2012 Apr 17.
8
The coagulopathy of chronic liver disease.
N Engl J Med. 2011 Jul 14;365(2):147-56. doi: 10.1056/NEJMra1011170.
9
Haemostatic profiles assessed by thromboelastography in patients with end-stage renal disease.
Thromb Haemost. 2011 Jul;106(1):67-74. doi: 10.1160/TH10-12-0785. Epub 2011 Jun 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验